Nearly 90 percent of young, otherwise healthy adults dealing with a severe case of COVID-19 died after not receiving a life-saving treatment while in the hospital, a recent study reveals. Concerningly, it’s not because these patients didn’t qualify for the treatment — they did — it’s because hospitals did not have the resources to get these individuals proper care.

Researchers from Vanderbilt University Medical Center (VUMC) say that treatment is extracorporeal membrane oxygenation (ECMO). According to the Mayo Clinic, ECMO pumps a patient’s blood out of their body to a heart-lung machine which removes carbon dioxide. From there, it sends oxygen-filled blood back to the patient’s tissues. The process allows blood to bypass the heart and lungs, giving those organs a chance to rest and heal.

Source: 9 in 10 young adults with COVID died due to shortage of life-saving treatment, study reveals